BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2072670)

  • 1. Laryngeal electromyographic activity in adductor and abductor spasmodic dysphonia.
    Watson BC; Schaefer SD; Freeman FJ; Dembowski J; Kondraske G; Roark R
    J Speech Hear Res; 1991 Jun; 34(3):473-82. PubMed ID: 2072670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adductor muscle activity abnormalities in abductor spasmodic dysphonia.
    Cyrus CB; Bielamowicz S; Evans FJ; Ludlow CL
    Otolaryngol Head Neck Surg; 2001 Jan; 124(1):23-30. PubMed ID: 11228447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laryngeal muscle activity during speech breaks in adductor spasmodic dysphonia.
    Nash EA; Ludlow CL
    Laryngoscope; 1996 Apr; 106(4):484-9. PubMed ID: 8614226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laryngeal long latency response conditioning in abductor spasmodic dysphonia.
    Deleyiannis FW; Gillespie M; Bielamowicz S; Yamashita T; Ludlow CL
    Ann Otol Rhinol Laryngol; 1999 Jun; 108(6):612-9. PubMed ID: 10378532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Listening: the key to diagnosing spasmodic dysphonia.
    Braden MN; Hapner ER
    ORL Head Neck Nurs; 2008; 26(1):8-12. PubMed ID: 18274236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of muscle activation patterns in adductor and abductor spasmodic dysphonia.
    Van Pelt F; Ludlow CL; Smith PJ
    Ann Otol Rhinol Laryngol; 1994 Mar; 103(3):192-200. PubMed ID: 8122835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges.
    Barkmeier JM; Case JL; Ludlow CL
    J Commun Disord; 2001; 34(1-2):21-37. PubMed ID: 11322567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a telephone screening tool for spasmodic dysphonia and vocal fold tremor.
    Johnson DM; Hapner ER; Klein AM; Pethan M; Johns MM
    J Voice; 2014 Nov; 28(6):711-5. PubMed ID: 24962230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical analyses of electromyographic activity in spasmodic dysphonic and normal control subjects.
    Watson BC; McIntire D; Roark RM; Schaefer SD
    J Voice; 1995 Mar; 9(1):3-15. PubMed ID: 7757148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acoustic variations in adductor spasmodic dysphonia as a function of speech task.
    Sapienza CM; Walton S; Murry T
    J Speech Lang Hear Res; 1999 Feb; 42(1):127-40. PubMed ID: 10025549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in adductor spasmodic dysphonia: acoustic evidence.
    Sapienza CM; Murry T; Brown WS
    J Voice; 1998 Jun; 12(2):214-22. PubMed ID: 9649077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior cricoarytenoid myoplasty with medialization thyroplasty in the management of refractory abductor spasmodic dysphonia.
    Shaw GY; Sechtem PR; Rideout B
    Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):303-6. PubMed ID: 12731624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electromyographic study of psychogenic dysphonias].
    Canals Ruiz P; Villoslada Prieto C; Marco Peiró A; López Catalá F; Peris Beaufils JL
    Acta Otorrinolaringol Esp; 1998; 49(5):400-3. PubMed ID: 9717331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acoustic measures of symptoms in abductor spasmodic dysphonia.
    Edgar JD; Sapienza CM; Bidus K; Ludlow CL
    J Voice; 2001 Sep; 15(3):362-72. PubMed ID: 11575633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injection.
    Rodriquez AA; Ford CN; Bless DM; Harmon RL
    Electromyogr Clin Neurophysiol; 1994; 34(7):403-7. PubMed ID: 7859668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report.
    Rontal M; Rontal E; Rolnick M; Merson R; Silverman B; Truong DD
    Laryngoscope; 1991 Aug; 101(8):911-4. PubMed ID: 1865744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consistency of voice produced by patients with adductor spasmodic dysphonia: a preliminary investigation.
    Cimino-Knight AM; Sapienza CM
    J Speech Lang Hear Res; 2001 Aug; 44(4):793-802. PubMed ID: 11521772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal phonatory characteristics after botulinum toxin type A injection.
    Fisher KV; Scherer RC; Guo CG; Owen AS
    J Speech Hear Res; 1996 Oct; 39(5):968-80. PubMed ID: 8898251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of recurrent laryngeal nerve resection for adductor spasmodic dysphonia.
    Fritzell B; Hammarberg B; Schiratzki H; Haglund S; Knutsson E; Mårtensson A
    J Voice; 1993 Jun; 7(2):172-8. PubMed ID: 8353632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A separation of innate and learned vocal behaviors defines the symptomatology of spasmodic dysphonia.
    Guiry S; Worthley A; Simonyan K
    Laryngoscope; 2019 Jul; 129(7):1627-1633. PubMed ID: 30582159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.